Tafnat Tablet 30 is used to treat chronic hepatitis B virus (HBV) infection) in adults and adolescents aged 12 years and above with compensated liver disease. Containing Tenofovir alafenamide, a nucleotide reverse transcriptase inhibitor (NRTI), it works by reducing viral replication in the body, helping to slow the progression of liver damage and improve liver function.
In addition to managing chronic HBV infection, this medicine can also be used to manage symptoms associated with chronic HBV such as fatigue, anxiety, loss of appetite, jaundice, seizures, and vomiting. It may also be used as part of a combination therapy for the treatment of HIV-1 infection along with other antiretroviral medicines.
This medicine should be taken orally as directed by your doctor. Before starting the medicine, inform your doctor about any pre-existing conditions you may have, especially liver or kidney disease, and any other medications you are currently taking. If you notice any side effects while taking this medicine, notify your doctor promptly. Continue taking the medicine for the full duration prescribed by your doctor for optimal results.















































































